I ka hakakā ʻana o ka lāhui i ka maʻi maʻi maʻi maʻi, ʻo ka mea kaua pono e hoʻolaha nui ʻia i nā maʻi he hoʻokahi hapaha liʻiliʻi a hiki ke hoʻohana ʻia ma ka ʻōpū a i ʻole ka lima.
Hoʻolako ʻia nā mākaʻikaʻi glucose koko mau me kahi mea ʻike liʻiliʻi e kūpono ana ma lalo o ka ʻili, e hōʻemi ana i ka pono o nā maʻi e ʻō i ko lākou mau manamana lima i kēlā me kēia lā e nānā i ka glucose koko.Mālama ka monitor i ka pae glucose, hoʻouna i ka heluhelu i ke kelepona paʻa a me ke kauka o ka mea maʻi, a hoʻomaopopo i ka mea maʻi ke kiʻekiʻe a haʻahaʻa paha ka heluhelu.
Wahi a ka ʻikepili mai ka hui hoʻopukapuka ʻo Baird, kokoke i 2 miliona mau kānaka i loaʻa i ka maʻi diabetes i kēia lā, ʻo ia ka pālua o ka helu ma 2019.
ʻAʻohe mea hōʻike liʻiliʻi e ʻoi aku ka maikaʻi o ka mālama ʻana i ka mālama ʻana i ka glucose koko (CGM) no ka hapa nui o nā maʻi maʻi maʻi - ʻōlelo ka poʻe loea olakino he 25 miliona mau kānaka me ka maʻi ʻano 2 ma ʻAmelika ʻaʻole i loaʻa nā inikini insulin e hoʻoponopono i ko lākou koko koko.Eia nō naʻe, ua ʻōlelo ka mea hana, a me kekahi mau kauka a me nā ʻoihana ʻinikua, e hoʻohālikelike ʻia i ka hoʻāʻo ʻana i ka manamana lima i kēlā me kēia lā, kōkua ka mea hana i nā mea maʻi e hoʻomalu i ka maʻi diabetes ma o ka hāʻawi ʻana i nā pane kokoke koke e hoʻololi i ka meaʻai a me ka hoʻoikaika kino.'Ōlelo lākou, hiki i kēia ke ho'ēmi i nā pilikia nui o nā maʻi, e like me ka puʻuwai puʻuwai a me ka hahau.
Ua ʻōlelo ʻo Kauka Silvio Inzucchi, ka luna o ka Yale Diabetes Center, ʻaʻole maikaʻi ka nānā ʻana i ka glucose koko no nā poʻe maʻi me ka maʻi maʻi type 2 i hoʻohana ʻole i ka insulin.
Ua ʻōlelo ʻo ia, ʻoi aku ka maʻalahi o ka hoʻokuʻu ʻana i ka hāmeʻa mai ka lima aku i hoʻokahi manawa i kēlā me kēia pule ʻelua ma mua o ka loaʻa ʻana o nā lāʻau manamana lima i emi iho ma mua o $1 i ka lā.Akā "no nā maʻi maʻi maʻi maʻi type 2, ʻaʻole kūpono ke kumukūʻai o kēia mau mea hana a ʻaʻole hiki ke hoʻohana mau ʻia."
Me ka ʻole o ka ʻinikua, ʻo ke kumukūʻai makahiki o ka hoʻohana ʻana i ka nānā ʻana i ka glucose koko mau ma waena o $1,000 a me $3,000.
Pono ka poʻe me ka maʻi maʻi type 1 (ʻaʻole i hana i ka insulin) i ka ʻikepili pinepine mai ka mākaʻikaʻi i mea e hoʻokomo ai i nā koina kūpono o nā hormones synthetic ma o ka pamu a i ʻole ka syringe.Ma muli o ka hiki ʻana o ka insulin i ka hāʻule ʻana o ke kō koko, e aʻo pū kēia mau mea hana i nā mea maʻi i ka wā e hiki mai ai kēia, ʻoi aku hoʻi i ka wā hiamoe.
ʻO ka poʻe maʻi me ka maʻi maʻi type 2 i loaʻa i kekahi maʻi ʻē aʻe, hana lākou i ka insulin e kāohi i ka piʻi ʻana o ke kō koko ma hope o ka ʻai ʻana, akā ʻaʻole pane ikaika ko lākou kino i ka poʻe me ka maʻi ʻole.Ma kahi o 20% o ka poʻe maʻi ʻano 2 e hoʻopaʻa mau nei i ka insulin no ka mea ʻaʻole hiki i ko lākou kino ke loaʻa i nā meaʻai kūpono a ʻaʻole hiki i nā lāʻau lapaʻau waha ke hoʻomalu i ko lākou maʻi diabetes.
Aʻo pinepine nā kauka i ka poʻe maʻi maʻi e hoʻāʻo i kā lākou glucose ma ka home e ʻike inā e loaʻa ana lākou i nā pahuhopu lapaʻau a e hoʻomaopopo i ka hopena o ka lāʻau lapaʻau, ka meaʻai, ka hoʻoikaika kino, a me ke kaumaha.
Eia naʻe, ʻo kahi hoʻāʻo koko koʻikoʻi a nā kauka e hoʻohana ai no ka nānā ʻana i ka maʻi maʻi i ka poʻe maʻi me ka maʻi ʻano 2 i kapa ʻia he hemoglobin A1c, hiki ke ana i ke kiʻekiʻe o ke kō koko no ka manawa lōʻihi.ʻAʻole ʻike ʻia ka hoʻāʻo ʻana o ka manamana lima a i ʻole ka nānā ʻana i ka glucose koko iā A1c.No ka nui o ke koko o keia hoao ana, aole hiki ke hana ia ma ke keena hana.
ʻAʻole noʻonoʻo ka nānā ʻana i ka glucose koko mau.Akā, ua ana lākou i nā pae glucose ma waena o nā ʻiʻo, ʻo ia nā kiʻekiʻe o ke kō i loaʻa i loko o ka wai ma waena o nā cell.
Me he mea lā ua paʻa ka ʻoihana e kūʻai aku i ka monitor i nā maʻi maʻi maʻi maʻi 2 (ʻo nā poʻe ʻelua e hoʻokomo i ka insulin a me nā poʻe ʻaʻole) no ka mea he mākeke kēia ma mua o 30 miliona mau kānaka.Ma kahi hoʻohālikelike, ma kahi o 1.6 miliona mau kānaka i loaʻa i ka maʻi diabetes type 1.
ʻO ka hāʻule ʻana o nā kumukūʻai ke hoʻonui nei i ka ulu ʻana o ka noi no nā hōʻike.ʻO Abbott's FreeStyle Libre kekahi o nā hōʻailona alakaʻi a haʻahaʻa loa.Ua kūʻai ʻia ka hāmeʻa ma US $70 a me ke kumukūʻai o ka sensor ma kahi o US $75 i kēlā me kēia mahina, pono e hoʻololi ʻia i kēlā me kēia pule ʻelua.
Aneane nā ʻoihana ʻinikua a pau e hāʻawi i ka nānā ʻana i ka glucose koko mau no ka poʻe me ka maʻi maʻi type 1, he mauʻu ola ola maikaʻi ia no lākou.Wahi a Baird, kokoke i ka hapalua o ka poʻe me ka maʻi maʻi type 1 ke hoʻohana nei i nā mea nānā.
Ua hoʻomaka kekahi helu liʻiliʻi akā e ulu nei o nā hui ʻinikua e hāʻawi i ka ʻinikua olakino no kekahi mau maʻi ʻano 2 ʻaʻole hoʻohana i ka insulin, me UnitedHealthcare a me Maryland-based CareFirst BlueCross BlueShield.Ua ʻōlelo kēia mau ʻinikua ua loaʻa iā lākou ka kūleʻa mua i ka hoʻohana ʻana i nā mākaʻikaʻi a me nā kumu aʻoaʻo olakino e kōkua i ka mālama ʻana i kā lākou mau lālā maʻi diabetes.
ʻO kekahi o nā haʻawina liʻiliʻi (i uku nui ʻia e ka mea hana mea hana, a me ke kumu kūʻai haʻahaʻa) ua aʻo i ka hopena o nā mea nānā i ke olakino o nā maʻi, a ua hōʻike nā hopena i nā hopena kū'ē i ka hōʻemi ʻana i ka hemoglobin A1c.
Ua ʻōlelo ʻo Inzucchi, ʻoiai me kēia, ua kōkua ka mea nānā i kekahi o kāna mau maʻi ʻaʻole makemake i ka insulin a ʻaʻole makemake e hou i ko lākou mau manamana lima e hoʻololi i kā lākou mau meaʻai a hoʻohaʻahaʻa i ko lākou koko koko.Ua ʻōlelo nā kauka, ʻaʻohe o lākou hōʻike e hiki i nā heluhelu ke hoʻololi mau i ka ʻai a me nā hana hoʻoikaika kino.'Ōlelo lākou he nui ka poʻe maʻi i hoʻohana ʻole i ka insulin e ʻoi aku ka maikaʻi o ka hele ʻana i nā papa hoʻonaʻauao maʻi diabetes, hele i nā gym a i ʻole ke ʻike ʻana i kahi meaʻai meaʻai.
Ua ʻōlelo ʻo Kauka Katrina Donahue, ka luna noiʻi o ke Keʻena ʻOihana ʻohana ma ke Kulanui o North Carolina: "Ma muli o kā mākou mau hōʻike i loaʻa, manaʻo wau ʻaʻohe waiwai ʻē aʻe o CGM i kēia heluna."“ʻAʻole maopopo iaʻu no ka hapa nui o nā maʻi., ʻO ka ʻenehana hou aʻe ka pane kūpono."
ʻO Donahue ka mea kākau kumu o kahi noiʻi ʻāina ma JAMA Internal Medicine ma 2017. Ua hōʻike ʻia ka haʻawina i hoʻokahi makahiki ma hope, ʻaʻole pono ka hoʻāʻo ʻana i ka manamana lima e nānā mau i ke kiʻekiʻe o ka glucose koko o nā maʻi me ka maʻi diabetes type 2 ʻaʻole pono no ka hoʻohaʻahaʻa ʻana i ka hemoglobin A1c.
Ke manaʻoʻiʻo nei ʻo ia, i ka wā lōʻihi, ʻaʻole i hoʻololi kēia mau ana i ka meaʻai a ka mea maʻi a me nā hana hoʻomaʻamaʻa hoʻomaʻamaʻa-pēia paha no ka nānā mau ʻana i ka glucose koko.
ʻO Veronica Brady, he loea hoʻonaʻauao diabetes ma ke Kulanui o Texas Health Science Center a he waha ʻōlelo no ka Association of Diabetes Care and Education Experts, i ʻōlelo: "Pono mākou e makaʻala i ka hoʻohana ʻana iā CGM."Ua ʻōlelo ʻo ia inā pono kēia mau mea nānā i kekahi mau pule i ka wā e hoʻololi ai i nā lāʻau lapaʻau e pili ana i ke kiʻekiʻe o ke kō koko, a i ʻole no ka poʻe i lawa ʻole ka hiki ke hana i nā hoʻokolohua manamana lima.
Eia naʻe, manaʻo kekahi poʻe maʻi e like me Trevis Hall e hiki i ka monitor ke kōkua iā lākou e hoʻomalu i ko lākou maʻi.
ʻO ka makahiki i hala aku nei, ma ke ʻano o ka hoʻolālā e kōkua i ka hoʻomalu ʻana i kona maʻi maʻi diabetes, ua hāʻawi ka papahana olakino ʻo Hall "United Healthcare" iā ia me nā mākaʻikaʻi no ka manuahi.Ua ʻōlelo ʻo ia ʻo ka hoʻopili ʻana i ka monitor i ka ʻōpū ʻelua i ka mahina ʻaʻole ia e hōʻeha i ka pilikia.
Hōʻike ka ʻikepili i ʻōlelo ʻo Hall, 53, mai Fort Washington, Maryland, e piʻi ana kāna glucose i nā pae weliweli i ka lā.Ua ʻōlelo ʻo ia e pili ana i ke ala ala e hoʻouna ʻia ai ke kelepona i ke kelepona: "He haʻalulu i ka wā mua."
I nā mahina i hala iho nei, ua kōkua kēia mau heluhelu iā ia e hoʻololi i kāna ʻai a me nā ʻano hoʻoikaika kino e pale ai i kēia mau spike a hoʻopaʻa i ka maʻi.I kēia mau lā, ʻo ia ka hele wikiwiki ʻana ma hope o ka ʻai ʻana a i ʻole ka ʻai ʻana i nā mea kanu i ka ʻaina ahiahi.
Ua hoʻohana kēia mau mea hana i nā miliona miliona e koi aku i nā kauka e kuhikuhi i ka nānā ʻana i ka glucose koko mau, a ua hoʻolaha pololei lākou i nā maʻi ma ka Pūnaewele a me nā hoʻolaha TV, me ka Super Bowl o kēia makahiki e ka mea mele Nick Jonas (Nick Jonas).Jonas) e hōʻike ana i nā pāʻoihana ola.
ʻO Kevin Sayer, Luna Nui o Dexcom, kekahi o nā mea hana nui o nā hōʻike, i haʻi aku i nā mea loiloi i ka makahiki i hala ʻo ka mākeke non-insulin type 2 ka wā e hiki mai ana."Haʻi pinepine kā mākou hui iaʻu i ka wā e ulu ai kēia mākeke, e pahū ia.ʻAʻole ia e liʻiliʻi, ʻaʻole e lohi, "wahi āna.
Ua hoʻohui ʻo ia: "Manaʻo wau e hoʻohana mau nā mea maʻi i ke kumukūʻai kūpono a me ka hopena kūpono."
Ka manawa hoʻouna: Mar-15-2021